Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects

Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects

Item
http://www.wikidata.org/entity/Q34447932
Anxiolytic-like effects of 4-phenyl-2-trichloromethyl-3H-1, 5-benzodiazepine hydrogen sulfate in mice.Should we tolerate tolerability as an objective in early drug development?The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery.Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults.Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.A novel maturation function for clearance of the cytochrome P450 3A substrate midazolam from preterm neonates to adults.Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.
P2860

Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects

Item
http://www.wikidata.org/entity/Q34447932
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Integrated pharmacokinetics an ...... ation to healthy male subjects
@ast
Integrated pharmacokinetics an ...... ation to healthy male subjects
@en
Integrated pharmacokinetics an ...... ation to healthy male subjects
@nl
type
label
Integrated pharmacokinetics an ...... ation to healthy male subjects
@ast
Integrated pharmacokinetics an ...... ation to healthy male subjects
@en
Integrated pharmacokinetics an ...... ation to healthy male subjects
@nl
prefLabel
Integrated pharmacokinetics an ...... ation to healthy male subjects
@ast
Integrated pharmacokinetics an ...... ation to healthy male subjects
@en
Integrated pharmacokinetics an ...... ation to healthy male subjects
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Integrated pharmacokinetics an ...... ation to healthy male subjects
@en
P2093
P304
P31
P356
10.1046/J.1365-2125.1997.T01-1-00613.X
P407
P433
P478
P577
P5875
P698
P932